New drug ZE50-0134 passes first safety check in healthy people
NCT ID NCT06787131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This was a first-in-human study to see if ZE50-0134 is safe and how it behaves in the body. 104 healthy adults received either the drug or a placebo. The study also looked at how the drug interacts with other medications like rabeprazole and itraconazole. Since this was only in healthy volunteers, it does not test any disease treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ZE50-0134
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Scientia Clinical Research
Sydney, Randwick NSW, 2031, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test